You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (288)

Journals (0)

1-10 of 288 results for EGFR-tyrosine kinase inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Open access

Research article

First published 2018

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

Po-Lan Su, Yi-Lin Wu, Wei-Yuan Chang [...]

Therapeutic Advances in Medical Oncology

Select article: Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Cancer

Open access

Research article

First published 2022

Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Cancer

Xiaotong Lu, Jingbo Wang, Chunyu Wang [...]

Clinical Medicine Insights: Oncology

Select article: Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study

Open access

Research article

First published 2025

Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study

Qi-An Wang, I-Lin Tsai, Chien-Yu Lin [...]

Therapeutic Advances in Medical Oncology

Select article: EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Retricted access

Review article

First published 2021-10

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Arafat Tfayli, Razan Mohty

Tumori Journal

Select article: Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Select article: Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR,ALK and ROS1 tyrosine kinase inhibitors: An update

Open access

Research article

First published 2024-03-19

Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR,ALK and ROS1 tyrosine kinase inhibitors: An update

Joanna Moes-Sosnowska, Adam Szpechcinski, Joanna Chorostowska-Wynimko

Tumor Biology

Select article: EGFR Gene Copy Number as a Predictive/Biomarker for Patients with Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitor Treatment: A Systematic Review and Meta-Analysis

Retricted access

Research article

First published 2017-1

EGFR Gene Copy Number as a Predictive/Biomarker for Patients with Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitor Treatment: A Systematic Review and Meta-Analysis

Xin Zhang, Yiwen Zhang, Hailing Tang [...]

Journal of Investigative Medicine

Select article: EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells

Free access

Research article

First published 2021-12

EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells

X Ge, Y Zhang, F Huang [...]

Human & Experimental Toxicology

Select article: Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

Open access

Review article

First published 2020-9

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

R Donald Harvey, Val R Adams, Tyler Beardslee [...]

Journal of Oncology Pharmacy Practice

Select article: The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Open access

Review article

First published 2012

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Chao H. Huang, Benjamin C. Powers

Clinical Medicine Insights: Oncology

1
2
3
•••
29
10 / page

Article type

Publication date

Subjects

Access